Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 193Squamous Cell Carcinoma of Head and Neck 171Oropharyngeal Neoplasms 35Carcinoma, Squamous Cell 26Nasopharyngeal Carcinoma 24Laryngeal Neoplasms 21Mouth Neoplasms 20Radiation Injuries 15Nasopharyngeal Neoplasms 12Hypopharyngeal Neoplasms 12Salivary Gland Neoplasms 11Xerostomia 8Neoplasms 8Mucositis 7Laryngeal Diseases 7Tongue Neoplasms 6Esthesioneuroblastoma, Olfactory 6Carcinoma, Non-Small-Cell Lung 6Carcinoma 6Thyroid Neoplasms 5Lung Neoplasms 5Recurrence 4Prostatic Neoplasms 4Melanoma 4Breast Neoplasms 4Thyroid Carcinoma, Anaplastic 3Rectal Neoplasms 3Pharyngeal Neoplasms 3Paranasal Sinus Neoplasms 3Pancreatic Neoplasms 3

Interventions

toripalimab 1Radiotherapy 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Radiotherapy × Head & Neck × Clear all
NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡